135 related articles for article (PubMed ID: 14567067)
1. Adenoviral delivery of a constitutively active retinoblastoma mutant inhibits neointima formation in a human explant model for vein graft disease.
Lamfers ML; Aalders MC; Grimbergen JM; de Vries MR; Kockx MM; van Hinsbergh VW; Quax PH
Vascul Pharmacol; 2002 Dec; 39(6):293-301. PubMed ID: 14567067
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral activin a expression prevents intimal hyperplasia in human and murine blood vessels by maintaining the contractile smooth muscle cell phenotype.
Engelse MA; Lardenoye JH; Neele JM; Grimbergen JM; De Vries MR; Lamfers ML; Pannekoek H; Quax PH; De Vries CJ
Circ Res; 2002 May; 90(10):1128-34. PubMed ID: 12039804
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein.
Tanner FC; Largiadèr T; Greutert H; Yang Z; Lüscher TF
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):20-6. PubMed ID: 14752408
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of the urokinase-type plasminogen activator receptor-targeted matrix metalloproteinase inhibitor TIMP-1.ATF suppresses neointima formation more efficiently than tissue inhibitor of metalloproteinase-1.
Lamfers ML; Grimbergen JM; Aalders MC; Havenga MJ; de Vries MR; Huisman LG; van Hinsbergh VW; Quax PH
Circ Res; 2002 Nov; 91(10):945-52. PubMed ID: 12433840
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral expression of a urokinase receptor-targeted protease inhibitor inhibits neointima formation in murine and human blood vessels.
Quax PH; Lamfers ML; Lardenoye JH; Grimbergen JM; de Vries MR; Slomp J; de Ruiter MC; Kockx MM; Verheijen JH; van Hinsbergh VW
Circulation; 2001 Jan; 103(4):562-9. PubMed ID: 11157723
[TBL] [Abstract][Full Text] [Related]
6. Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation.
Smith RC; Wills KN; Antelman D; Perlman H; Truong LN; Krasinski K; Walsh K
Circulation; 1997 Sep; 96(6):1899-905. PubMed ID: 9323079
[TBL] [Abstract][Full Text] [Related]
7. Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
Hata JA; Petrofski JA; Schroder JN; Williams ML; Timberlake SH; Pippen A; Corwin MT; Solan AK; Jakoi A; Gehrig TR; Kontos CD; Milano CA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1405-13. PubMed ID: 15942585
[TBL] [Abstract][Full Text] [Related]
8. Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle cell migration and induction of apoptosis.
George SJ; Angelini GD; Capogrossi MC; Baker AH
Gene Ther; 2001 May; 8(9):668-76. PubMed ID: 11406761
[TBL] [Abstract][Full Text] [Related]
9. Role of Girdin in intimal hyperplasia in vein grafts and efficacy of atelocollagen-mediated application of small interfering RNA for vein graft failure.
Miyachi H; Mii S; Enomoto A; Murakumo Y; Kato T; Asai N; Komori K; Takahashi M
J Vasc Surg; 2014 Aug; 60(2):479-489.e5. PubMed ID: 23948670
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.
Kallenbach K; Salcher R; Heim A; Karck M; Mignatti P; Haverich A
J Vasc Surg; 2009 Mar; 49(3):750-8. PubMed ID: 19268777
[TBL] [Abstract][Full Text] [Related]
11. Distribution of endothelin-1 (ET) receptors (ET(A) and ET(B)) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts.
Dashwood MR; Mehta D; Izzat MB; Timm M; Bryan AJ; Angelini GD; Jeremy JY
Atherosclerosis; 1998 Apr; 137(2):233-42. PubMed ID: 9622266
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated gene transfer of fibromodulin inhibits neointimal hyperplasia in an organ culture model of human saphenous vein graft disease.
Ranjzad P; Salem HK; Kingston PA
Gene Ther; 2009 Sep; 16(9):1154-62. PubMed ID: 19474808
[TBL] [Abstract][Full Text] [Related]
13. Early growth response gene-1 decoy oligonucleotides inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of autogenous vein graft in rabbits.
Wang X; Mei Y; Ji Q; Feng J; Cai J; Xie S
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):50-4. PubMed ID: 25820759
[TBL] [Abstract][Full Text] [Related]
14. Vascular-wall remodeling of 3 human bypass vessels: organ culture and smooth muscle cell properties.
Mekontso-Dessap A; Kirsch M; Guignambert C; Zadigue P; Adnot S; Loisance D; Eddahibi S
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):651-8. PubMed ID: 16515919
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration.
Porter KE; Naik J; Turner NA; Dickinson T; Thompson MM; London NJ
J Vasc Surg; 2002 Jul; 36(1):150-7. PubMed ID: 12096273
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-221 sponge therapy attenuates neointimal hyperplasia and improves blood flows in vein grafts.
Wang XW; He XJ; Lee KC; Huang C; Hu JB; Zhou R; Xiang XY; Feng B; Lu ZQ
Int J Cardiol; 2016 Apr; 208():79-86. PubMed ID: 26828387
[TBL] [Abstract][Full Text] [Related]
17. Human saphenous vein organ culture: a useful model of intimal hyperplasia?
Porter KE; Varty K; Jones L; Bell PR; London NJ
Eur J Vasc Endovasc Surg; 1996 Jan; 11(1):48-58. PubMed ID: 8564487
[TBL] [Abstract][Full Text] [Related]
18. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of intimal hyperplasia.
Petrofski JA; Hata JA; Gehrig TR; Hanish SI; Williams ML; Thompson RB; Parsa CJ; Koch WJ; Milano CA
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):27-33. PubMed ID: 14752409
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of p53 increases lumen size and blocks neointima formation in porcine interposition vein grafts.
Wan S; George SJ; Nicklin SA; Yim AP; Baker AH
Mol Ther; 2004 May; 9(5):689-98. PubMed ID: 15120330
[TBL] [Abstract][Full Text] [Related]
20. Proliferative activity in stenotic human aortocoronary bypass grafts.
Hilker M; Tellmann G; Buerke M; Gloger K; Moersig W; Oelert H; Hake U; Lehr HA
Cardiovasc Pathol; 2002; 11(5):284-90. PubMed ID: 12361839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
